Objective: The present study reports on the important issue of how family communication and support regarding breast cancer risk affects interest in genetic testing and mental health. Methods: Participants (n = 221) were women aged 18–74 who had at least one relative of Ashkenazi Jewish descent, no personal history of breast or ovarian cancer, and lived within 60 miles of Seattle, Wash. Results: Communication about breast cancer risk was reported with very low frequency across all types of relatives. Women talked with their mothers and sisters more often than their fathers, brothers, or children. The only significant predictor of interest in genetic testing was the individual level variable of seeking social support. Conclusion: Social support needs might be a part of the genetic testing process.

1.
Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W: Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in Western Washington. Cancer Epidemiol Biomarkers Prev 1999;8:369–375.
2.
Chalmers K, Thomson K, Degner LF: Information, support, and communication needs of women with a family history of breast cancer. Cancer Nurs 1996;19:204–213.
3.
Carter CA, Carter RE: Some observations on individual and marital therapy with breast cancer patients and spouses. J Psychosoc Oncol 1994;12:65–81.
4.
Lewis FM: The relational model of functioning with cancer: A family focused framework for nursing practice; in Miaskowski C, Buchsel P (eds): Cancer across Health Care Sites. St Louis, Mosby Year Book, 1999, pp 319–331.
5.
Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C, Main D: All in the family: Evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 2002;107:143–150.
6.
Holtzman NA, et al: Interim Principles of the Task Force on Genetic Testing of the NIH-DOE Working Group on Ethical, Legal, and Social Implications of Human Genome Research. Baltimore, National Center for Human Genome Research, 1996.
7.
Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995;11:198–200.
8.
Stolberg SG: Concern among Jews is heightened as scientists deepen gene studies. New York Times, April 22, p. A24, 1998.
9.
Olson D, Bell R, Portner J: FACES II: Family Version. St Paul, Family Social Science, University of Minnesota, 1991.
10.
McCubbin HI, Thompson AI, McCubbin MA: Family Assessment: Resiliency, Coping, and Adaptation. Madison, University of Wisconsin Publishers, 1996.
11.
Ell K: Social networks, social support and coping with serious illness: The family connection. Soc Sci Med 1996;42:173–183.
12.
Folkman S, Lazarus RS: An analysis of coping in a middle-aged community sample. J Health Soc Behav 1980;21:219–239.
13.
Sherbourne CD, Stewart AL: The MOS social support survey. Soc Sci Med 1991;32:705–714.
14.
Ware JE: SF 36 Health Survey: Manual and Interpretation Guide. Boston, The Health Institute, New England Medical Center, 1993.
15.
Baron RM, Kenny DA: The moderator-mediator variable distinction in social psychological research: Conceptual, strategic and statistical considerations. J Pers Soc Psychol 1986;51:1173–1182.
16.
Julian-Reynier C, Eisinger F, Chabal F, Lasset C, Nogues C, Stoppa-Lyonnet D, Vennin P, Sobol H: Disclosure to the family of breast/ovarian cancer genetic test results: Patient’s willingness and associated factors. Am J Med Genet 2000;94:13–18.
17.
Barnes J, Kroll L, Burke O, Lee J, Jones A, Stein A: Qualitative interview study of communication between parents and children about maternal breast cancer. BMJ 2000;321:479–482.
18.
Bloom JR, Spiegel D: The relationship of two dimensions of social support to the psychological well-being and social functioning of women with advanced breast cancer. Soc Sci Med 1984;19:831–837.
19.
Pistrang N, Barker C: The partner relationship in psychological response to breast cancer. Soc Sci Med 1995;40:789–797.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.